Clinical Trials Logo

Filter by:
  • Completed  
  • Page [1] ·  Next »
NCT ID: NCT06379620 Completed - Clinical trials for Post COVID-19 Condition

Pilot Open Label Use of the Hi-OXSR for the Treatment of Post COVID Cognitive Dysfunction

Hi-OXSR
Start date: November 29, 2022
Phase: Phase 1
Study type: Interventional

During the worldwide COVID-19 pandemic a large number patients reported different functional complaints one month or later after recovery from the acute infection. This entity had a number of names including "long-COVID" or "post COVID condition". Long-COVID is on the rise and no effective treatment exists yet to improve cognitive function. Recent research has shown that people with even mild COVID had a greater decline in executive function, notably in their ability to perform complex tasks. What drives post-COVID cognitive changes is still a mystery and there are no effective treatments available. One hypothesis is that there is persistent immune activation resulting in reduction in cerebral blood flow. There is evidence that increased CO2 may decrease inflammation, and decreased CO2 may increase inflammation. Objectives: The primary objective of this pilot study is to assess the safety and tolerability of the use of Hi-OX sequential rebreathing for the treatment of post-COVID cognitive dysfunction. The secondary objective is to identify the effects of the use of the Hi-OX rebreathing treatment in changing post-COVID cognitive dysfunction.

NCT ID: NCT06361576 Completed - Clinical trials for Upper Gastrointestinal Cancer

Real-World Use of Nivolumab for the Treatment of Patients With Metastatic Upper Gastrointestinal Cancer in Canada

Start date: September 5, 2023
Phase:
Study type: Observational

The purpose of this observational study is to describe the demographics, and disease characteristics of participants with metastatic upper gastrointestinal cancer, along with the treatment characteristics of these patients when treated with nivolumab.

NCT ID: NCT06361563 Completed - Clinical trials for Upper Gastrointestinal Cancer

Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in Canada

Start date: September 5, 2023
Phase:
Study type: Observational

The purpose of this observational study is to describe the patient, disease and treatment characteristics of eligible participants with upper gastrointestinal cancer treated with adjuvant nivolumab.

NCT ID: NCT06357819 Completed - Hepatitis C Clinical Trials

INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation

Start date: October 12, 2023
Phase:
Study type: Observational

The purpose of this Interpretation Assessment was to document if "lay" people, non-professional and inexperienced in self-testing, were able to successfully perform the steps to use a Hepatitis C Virus (HCV) Self-Test (HCVST) device, without product familiarization [demonstration].

NCT ID: NCT06355817 Completed - Surgery Clinical Trials

Distraction Techniques in Periocular Anesthesia: Tapping vs Vibration

Start date: September 21, 2023
Phase: N/A
Study type: Interventional

To compare the efficacy of topical tapping vs vibration in lowering pain scores for periocular anesthesia injections.

NCT ID: NCT06353009 Completed - Clinical trials for Myocardial Endothelial Function

Effect of a Single Ultra-Processed Meal on Myocardial Endothelial Function Assessed With Positron Emission Tomography

SUPPER
Start date: August 20, 2020
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the effect of an ultra-processed meal on myocardial endothelial function using positron emission tomography (PET). The proposed study is an open-label, randomized crossover clinical trial. Participants will be divided into 2 groups: half of the participants will consume a Mediterranean meal during the first experimental visit and an ultra-processed meal during the second, and vice versa for the other half. The order in which the meals will be consumed will be determined randomly. This project will contribute to clarify the role of diet in the development and progression of coronary artery disease. The results obtained from this study may potentially demonstrate the harmful effect of ultra-processed foods, even in the short term, on coronary arteries.

NCT ID: NCT06348173 Completed - Asthma Clinical Trials

Response and Remission to Treatment With Anti-IL5/IL5R Antagonists

Start date: June 1, 2023
Phase:
Study type: Observational

The aim of this retrospective observational study is to compare the response and remission rate after treatment with IL5/IL5-R antagonists in asthmatics who would and would have not met the inclusion criteria of the original randomized clinical trials. This study will be performed using the charts of the patients.

NCT ID: NCT06346002 Completed - Clinical trials for Mental Health Wellness 1

Impact of a Mindfulness-based Intervention on Well-being and Mental Health of Elementary School Children

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

Background: Prevention programs for children such as mindfulness-based interventions (MBIs) are often implemented in schools to prevent psychological disorders from emerging and contribute to children' mental health. Aim: This study used a randomized cluster design and assessed the impact of a MBI on well-being and mental health of elementary school children's. Method: 13 elementary school classrooms were randomly allocated to the experimental condition (7 classrooms, n = 127 students) or the waitlist control condition (6 classrooms, n = 104 students). Participants in the experimental condition received a 10-week MBI.

NCT ID: NCT06345950 Completed - Safety Clinical Trials

Pharmacokinetics and Safety of a New Micellar Glutathione Formulation

Start date: June 21, 2022
Phase: N/A
Study type: Interventional

This study seeks to determine the short-term effects of daily oral supplementation with a new micellar Glutathione formulation (LipoMicel) on the oral absorption and safety of glutathione in healthy volunteers. The primary objective of this study is to evaluate and compare the pharmacokinetics of a novel micellar Glutathione (GSH) formulation with that of a standard formulation as well as a liposomal GSH formulation. The secondary objective is to evaluate the safety of a new micellar GSH formulation with higher bioavailability in human participants over a 30-day study period.

NCT ID: NCT06342232 Completed - Migraine Headaches Clinical Trials

The Efficacy of Neurofeedback Mindfulness in Migraine Management

Start date: September 9, 2021
Phase: N/A
Study type: Interventional

This longitudinal randomized controlled trial explored how long-term practice of neurofeedback mindfulness would be helpful for migraine management when compare dot a similar controlled intervention. All the participants went through assigned 10 minutes practices on a daily basis for 8 weeks. Behavioural reports and migraine characteristics were compared before and after the intervention.